| CPC A61B 5/4845 (2013.01) [A61B 5/0022 (2013.01); A61B 5/02055 (2013.01); A61B 5/024 (2013.01); A61B 5/0816 (2013.01); A61B 5/1112 (2013.01); A61B 5/117 (2013.01); A61B 5/681 (2013.01); A61B 5/746 (2013.01); G16H 15/00 (2018.01); H04W 4/02 (2013.01)] | 20 Claims |

|
1. An opioid overdose alert system, comprising:
a wearable device having physiological sensors, the wearable device configured to be worn by a user to continuously monitor vital signs of the user;
a chemical sensor coupled to the wearable device configured to identify and measure concentration levels of a predetermined drug that includes fentanyl and to determine if a predetermined level of fentanyl exists as a lethal concentration levels;
a global positioning location device coupled to the wearable device configured to continuously track a physical geographical location of the user;
an alert signaling device coupled to the wearable device and chemical sensor and configured to receive the lethal concentration level; and
a transmitter coupled to the alert signaling device and global positioning location device configured to automatically alert the user and a designated remote user of potential lethal overdosing based on the lethal concentration level and to transmit the vital signs and the physical geographical location of the user to the designated remote user.
|